43
. The functional significance of these unique domains is not well understood. The enzymatic activities of ADAR1 (REF. 41 ) and ADAR2 (REF. 42) have been demonstrated, but the A-to-I RNA-editing activity of ADAR3 is yet to be shown 43, 44, 47 . ADAR1 is ubiquitously expressed 41 , whereas ADAR2 is most highly expressed in the brain, but is also expressed in other tissues 42 . ADAR3 expression is restricted to the brain 43, 44 . In addition to these three ADARs, testis nuclear RNA-binding protein (TENR; also known as ADAD1), which is specifically expressed in testes and is required for spermato genesis 48 , and TENR-like (TENRL; also known as ADAD2), which is expressed in the brain 49 , have sequence and domain-structure similarity to ADAR but have no deaminase activity, owing to the
Deamination
The chemical process that replaces a primary amino group by a hydroxyl group, resulting in conversion of one nucleoside to another.
lack of amino acid residues that are crucial for the catalytic reaction. In Drosophila melanogaster, only a single ADAR2-like gene, dAdar, is present, and in Caenorhabditis elegans, two ADAR genes, adr1 and adr2, are known (FIG. 1a) . ADARs are absent in all protozoa, yeast and plants 40 .
Mechanism of deamination and editing-site selectivity.
During the A-to-I RNA editing process, adenosine is converted to inosine by hydrolytic deamination at the C6 position 2, 3 (FIG. 1b) . The translation machinery reads the inosine as if it were guanosine, base-pairing it with cytosine (FIG. 1b) . In this manner, A-to-I RNA editing can result in the incorporation of amino acids that are not directly encoded in the genome. X-ray crystallographic analysis of the catalytic domain of human ADAR2 revealed that His394, Glu396, Cys451 and C516 are involved in the coordination of a zinc ion and formation of the catalytic centre 50 . A base-flipping mechanism probably places the targeted adenosine in the catalytic pocket for the deamination reaction 50 . Structural studies also revealed the presence of inositol hexakisphosphate (InsP 6 ) buried within the enzyme core, surrounded by many Arg and Lys residues and located very close to the catalytic centre. The InsP 6 molecule is predicted to have a crucial role during the deamination reaction, although its exact function is currently not known 50 . ADAR acts on both inter-and intramolecular dsRNAs of >20 bp in length 51 . More than half of all adenosines of long (>100 bp), fully base-paired dsRNAs can be edited by ADARs. By contrast, only a few adenosines of short and/or partially base-paired dsRNAs are selectively edited, perhaps indicating that the secondary structure of substrates dictates editing-site selectivity 52 . For example, site selectivity in the glutamate receptor GRIA2 (formerly known as GluR2 and GluRB) precursor mRNA (pre-mRNA) at the Q/R site requires an intramolecular dsRNA structure that is formed between the exonic sequence around the editing site and a downstream intronic complementary sequence termed the ECS (editing site complementary sequence) 53 . Owing to this requirement for the intron, A-to-I editing at this site is believed to occur in the nucleus, either before or simultaneously with splicing. Although no strict sequence specificity is required for A-to-I RNA editing, a preference for editing adenines neighbouring 5′ uridine and 3′ guanosine has been reported 54 . Certain sites are edited by ADAR1 only or ADAR2 only, whereas other sites are edited equally well by both [54] [55] [56] [57] (TABLES 1, 2).
Regulation of ADAR expression and localization.
Transcription from separate promoters generates two isoforms of ADAR1, a full-length, interferon-inducible ADAR1p150 and a shorter and constitutively expressed ADAR1p110, which lacks the N-terminal portion of the protein, including the Zα domain 58, 59 (FIG. 1a) . ADAR2 expression is positively regulated by the transcription activator CREB (cyclic adenosine monophosphate response element-binding protein) in the brain 60 , and by c-Jun N-terminal kinase 1 (JNK1; also known as MAPK8) in pancreatic β-cells 61 . Interestingly, CREB also suppresses transcription from the ADAR1p110 promoter in metastatic melanomas 62 . Homodimerization is required for the A-to-I RNA-editing activities of ADAR1 and ADAR2 . The third dsRBD of ADAR1 and the first dsRBD of ADAR2 are required for their homodimerization 26, 64 . ADAR3 is unable to homodimerize, which may underlie its lack of A-to-I RNA editing activity 63 . Both ADAR1p150 and ADAR1p110 shuttle between the nucleus and the cytoplasm [66] [67] [68] (FIG. 2a) . Binding of the nuclear export factor exportin 1 (XPO1; also known as CRM1) to the nuclear export signal (NES) Figure1| Deamination of adenosine to inosine by adenosine deaminases acting on RNA (ADAR) proteins. a |ThreehumanADARfamilymembers(ADAR1,ADAR2and ADAR3), two human ADAD (adenosine deaminase domain-containing) family members (TENR and TENRL), Drosophila melanogaster dAdar, and two Caenorhabditis elegans ADARproteins(ADR-1andADR-2), share common functional domains. These include two or three repeats of the double-stranded RNA (dsRNA)-binding domain (dsRBD) and a catalyticdeaminasedomain.Certainstructuralfeatures,suchasZ-DNA-binding domains(ZαandZβ) and the Arg-rich, single-stranded RNA (ssRNA)-binding R domain, are unique to particular ADAR members. b | ADARs catalyse a hydrolytic deamination reaction that converts adenosine to inosine (top). Whereas adenosine base-pairs with uridine,inosinebehaveslikeaguanosine,asitbase-pairswithcytidineina Watson-Crick-bonding configuration (bottom). NES, nuclear export signal; NLS, nuclear localization signal. Part b reprinted with permission from REF. 5 , Annual Reviews.
Inositol hexakisphosphate (InsP 6 ). An intracellular organic compound that is found throughout the animal kingdom and is affiliated with a wide range of important physiological activities such as modulation of haemoglobin structure and function. located within the Zα domain, together with RANGTP, regulates nuclear export of ADAR1p150 (REF. 69 ). The nuclear localization signal (NLS) located in the third dsRBD is responsible for localization of ADAR1 in the nucleus and nucleolus 66, 68 . Nuclear export of ADAR1p110 is mediated by XPO5-RANGTP and is regulated by dsRNA binding to the dsRBDs, whereas nuclear import of ADAR1p110 is mediated by binding of transportin 1 (TRN1) to the third dsRBD, which is inhibited by binding of dsRNA 68, 70 . The predominantly nucleolar localization of ADAR2 is regulated by the binding of karyopherin subunit α1 (KPNA1) and KPNA3 (REF. 71) to an Arg-rich NLS in the N-terminal region 66, 71, 72 (FIG. 2b) . Post-translational modification regu lates the nuclear localization and stability of ADAR2. Phosphorylation of Thr32 activates ADAR2 interaction with the prolyl-isomerase PIN1 in a dsRNAbinding dependent manner, which isomerizes Pro33 and posi tively controls the nuclear localization and stabil ity of ADAR2. By contrast, the E3 ubiquitin ligase WWP2 promotes the degradation of ADAR2 in the cytoplasm 73 (FIG. 2b) . 75 , and the trafficking and proper localization of GABRA3 are reduced by editing of its I/M site 76 . Recent transcriptome deep sequencing and global screening for editing sites have revealed that the recoding type of A-to-I editing also occurs in genes other than those encoding neurotransmitter receptors and ion channels. However, recoding-type editing to any significant degree (>20% editing) is rare; the functions of ~80 mammalian genes in total might be regulated by A-to-I editing 7, 13, 15, [17] [18] [19] .
Deficiency in A-to-I RNA editing Adar2-null mutant mice die several weeks after birth following frequent epileptic seizures, which are caused by neuronal death owing to excess influx of Ca
2+
. This is a result of severe deficiency in the editing of an almost exclusive ADAR2 target, GRIA2 pre-mRNA, at its Q/R site 56 . Deficient editing of the Q/R site seems to underlie the loss of motor neurons in patients with sporadic amyotrophic lateral sclerosis (ALS) 77 , and death of motor neurons and other symptoms of ALS are indeed detected in motor neuron-specific knockouts of Adar2 in mice 78 . Furthermore, deficiency in GluR2 Q/R-site editing and the consequent excess Ca 2+ influx have been proposed to activate the kinase AKT and lead to glioblastoma proliferation 79 , as well as neuronal death in forebrain ischemia 60 . The inactivation of ADAR1 in mice results in an embryonic-lethal phenotype that is characterized by defective erythropoiesis, aberrant activation of interferon signalling and widespread apoptosis 55, 57, [80] [81] [82] . ADAR1 seems to protect organisms from the deleterious effects of interferon activation, which is relevant to many human pathological processes, such as chronic inflammation and autoimmune disorders 80 . The embryonic lethal phenotype of Adar1-null mice can be rescued by the simultaneous inactivation of mitochondrial antiviral signalling adaptor protein (MAVS) 83 or melanoma differentiation-associated protein 5 (MDA5; also known as IFIH1) 81 , the upstream genes involved in the interferon activation pathway. This indicates the relevance of ADAR1 function in the regulation of the interferon pathway to the embryonic-lethal phenotype of Adar1-null mice 81, 83 . Endogenous long dsRNAs produced from inverted retrotransposon repeats of the LINE (long interspersed nuclear elements) and SINE (short interspersed nuclear elements) families and located in the 3′ untranslated regions (UTRs) of several genes, such as Krüppel-like factor 1 (Klf1), optineurin (Optn), and OPA-interacting protein 5 homologue (Oip5), have been proposed as crucial ADAR1-substrate RNAs. Failure to edit these dsRNAs may lead to the activation of cytosolic dsRNA sensing by MDA5 and of MAVS-mediated interferon signalling in Adar1-null mouse embryos 81 .
Dysfunction of A-to-I editing causes human diseases.
Nine ADAR1 mutations were found in a subset of patients with Aicardi-Goutières syndrome (AGS) 84 . AGS is an autosomal-recessive inflammatory disorder that affects the brain and skin and is characterized by an aberrant immune response and increased interferon-α expression 84 . Failed editing of certain endogenous dsRNAs such as Alu by the mutant ADAR1, and the consequent activation of interferon signalling, seem to underlie the pathogenesis of AGS 83, 85 . Indeed, the overproduction of interferons is detected in the brains and spinal cords of conditional Adar1-null mice 85 . A large number of ADAR1 mutations (>130) are also associated with dyschromatosis symmetrica hereditaria (DSH), which is an autosomal-dominant disorder that is mainly found in Asian individuals and is characterized by hypo-and hyperpigmentation of the skin 86 . ADAR1 haploinsufficiency, as well as dominant-negative effects of the mutant ADAR1, are likely to underlie the pathogenesis of DSH 65, 86 . The 5-HT 2C R pre-mRNA is edited at five sites by ADAR1 and ADAR2 , and the combinatorial editing of these sites results in the expression of 24 protein isoforms. Mutant mouse lines expressing either the unedited or the fully edited forms of 5-HT 2C R have been established 87, 88 . Mutant mice expressing fully edited 5-HT 2C R had significantly decreased fat mass and increased energy expenditure, resulting from hyperactivation of the sympathetic nervous system, suggesting that 5-HT 2C R mRNA editing has a regulatory role in lipolysis and metabolism 87 . The same 5-HT 2C R mRNA-editing mutant mice exhibit a phenotype similar to Prader-Willi syndrome (PWS), which is characterized by obesity and a range of developmental 
Endogenous short interfering RNAs
(endo-siRNAs). siRNAs derived from endogenous double-stranded transcripts and repetitive elements such as Alu or other retrotransposons.
abnormalities 88 . However, the mutant mice lacked certain PWS-associated symptoms such as obesity, and thus the relevance of over-editing of 5-HT 2C R mRNA to PWS needs further investigation. The 5-HT 2C R mRNAediting mutant mice (both over-and under-edited) exhibit anti-depressive and exaggerated anxiety-like behaviours, indicating a relevance of 5-HT 2C R mRNA editing to psychiatric disorders 89 . An association of altered editing patterns of 5-HT 2C R with several psychi atric disorders, including anxiety, depression, bi polar disorder, schizophrenia and suicide, as well as with autism, has been reported, although the findings have often been inconsistent owing to the difficulty of analysing post-mortem human brain samples 28, 29, 90 .
Alu dsRNA editing and its implications Recent advances in sequencing technology, as well as in bioinformatics analyses of sequence databases, have made it possible to globally screen for previously unknown A-to-I editing sites in normal tissues and in various cancers. This has resulted in the identification of many millions of new editing sites in human transcripts [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Surprisingly, almost all of these new sites reside in introns and 3′ UTRs that harbour Alu dsRNAs. What is the fate of RNAs carrying highly edited Alu repeats? Are there any proteins that specifically recognize and interact with these highly edited RNAs? Are there any functions for highly edited Alu dsRNAs?
Exonization of intronic Alu sequences. An inosine is recognized by the splicing machinery as a guanosine. Thus, A-to-I editing of Alu sequences can generate splice donor and acceptor sites. For instance, AU-to-IU editing will generate a sequence that could be recognized as the canonical 5′ splice donor site GU (IU as GU), and AA-to-AI editing will generate a sequence that could be recognized as the 3′ splice acceptor site AG (AI as AG). Self-editing by ADAR2 of an intronic sequence of its own pre-mRNA indeed results in the creation of an alternative 3′ splice acceptor site and the suppression of ADAR2 expression, thereby functioning as a negative autoregulatory mechanism 91, 92 . A-to-I editingmediated exonization of Alu sequences (FIG. 3a) has been reported for several genes, including G proteincoupled receptor 107 (REF. 6), nuclear prelamin A 93 and seryl-tRNA synthetase 19 .
Retention of edited Alu dsRNAs in paraspeckles.
The inosine-specific RNA-binding protein p54 nrb was proposed to mediate the specific retention in nuclear paraspeckles of mRNAs containing extensively edited Alu dsRNA 94 (FIG. 3b) . At least 333 human genes contain Alu dsRNA sequences in their 3′ UTRs 95 . A-to-I editing and p54 nrb -dependent nuclear retention of transcripts of one such human gene, nicolin 1, has been demonstrated 95 . Another example is the mouse Ctn gene 96 . Ctn transcripts contain a long dsRNA formed of inverted repeats of mouse SINEs in the 3ʹ UTR 96 . Under conditions of stress, Ctn RNA is posttranscriptionally cleaved and polyadenylated at an alternative site, resulting in the loss of the edited SINE sequences and the release of the protein-coding mCat2 (also known as Slc7a2) mRNA to the cytoplasm, where it is translated into cationic amino acid transporter 2 proteins 96 (FIG. 3b) . More recent studies have revealed that the nuclear paraspeckle assembly transcript 1 (NEAT1), a long non-coding RNA, is also required for the formation of nuclear paraspeckles and for the retention mechanism. Human embryonic stem cells (ES cells) lack NEAT1 and do not form paraspeckles. Accordingly, LIN28 mRNAs containing extensively edited Alu dsRNA in their 3′ UTRs can be detected in the cytoplasm despite the presence of p54 nrb , indicating that both p54 nrb and NEAT1 are required for the retention mechanism 97 .
Degradation of edited Alu dsRNAs by endonuclease V.
A ribonuclease activity that specifically cleaves both RNA strands of a dsRNA that contains multiple I·U base pairs (that is, extensively edited Alu dsRNA) has been reported 98 . Endonuclease V (EndoV) was recently identi fied as this ribonuclease 99 . Tudor staphylo coccal nuclease (Tudor-SN) seems to promote the activity of EndoV as a cofactor 100 . Thus, A-to-I editing of Alu dsRNAs may lead to degradation by EndoV together with Tudor-SN, which in turn might control the expression levels of genes harbouring Alu dsRNA (FIG. 3c) . A-to-I hyperedited RNAs are easily detected in steady-state mRNA pools, and thus their degradation is not constitutive and must be regulated, perhaps by compartmentalization of EndoV and Tudor-SN: cytoplasmic as well as nucleolar localization of EndoV has been reported 99 , whereas Tudor-SN localizes to stress granules in stress conditions 101, 102 . Interestingly, ADAR1p150 seems to bind to extensively edited dsRNA via its Zα domain and localizes together with Tudor-SN to stress granules in stress conditions, although the roles of ADAR1p150 and Tudor-SN, as well as the fate of the extensively edited dsRNA in stress granules, remain to be established 102, 103 . Thus, EndoV-Tudor-SN could regulate the expression of genes containing extensively edited Alu dsRNA in special circumstances, for instance, during stress or viral infection.
Suppression of the interferon response.
The interferon signalling pathway is activated in response to infection by pathogens such as viruses and bacteria, as well as by long dsRNAs such as synthetic poly(I:C). A biological function for extensively edited dsRNAs in the suppression of the interferon signalling pathway has been proposed, using a synthetic dsRNA that contains multiple and consecutive IU-mismatched wobble base pairs (IU-dsRNA) 104 . IU-dsRNA, which resembles extensively edited Alu dsRNA, forms a unique configuration 104 and inhibits the activation of interferon signalling and of interferon-stimulated genes (ISGs) induced by poly(I:C) dsRNAs in cultured cell lines. The IU-dsRNA was proposed to competitively inhibit binding to poly(I:C) dsRNA by retinoic acid-inducible gene 1 (RIG1; also known as DDX58) or MDA5, both of which are cytosolic sensors for dsRNA and upstream regulators of the MAVS-mediated interferon activation (FIG. 3d) . The same IU-dsRNA was shown to suppress the interferon pathway that is aberrantly activated in Adar1-null mouse embryonic fibroblasts 83 . Recent studies identified LINE and SINE dsRNAs present in 3′ UTRs of Klf1, Optn, and Oip5 as candidate sources of endogenous IU-dsRNAs 81 . Failure in hyper-editing these dsRNAs by ADAR1 may lead to their sensing by RIG1 and MDA5, and consequent activation of MAVS-mediated interferon signalling, which is perhaps relevant to Adar1-null mouse phenotypes, as well as to the pathology of AGS 81 .
Heterochromatin formation and gene silencing. The involvement of RNAi and its components (such as endogenous short interfering RNAs (endo-siRNAs) and PIWI-interacting RNAs) in the establishment of heterochromatin and in silencing the expression of repetitive sequences and transposons is well known in plants, fission yeast and various other eukaryotes. However, it has been debated whether similar mechanisms operate in mammalian cells 105 . Interestingly, vigilin, which is a multi-KH-domain protein, binds to inosine-containing RNAs such as extensively edited Alu dsRNA and forms a complex with ADAR1, the KU86 (86 kDa subunit of Ku antigen; also known as XRCC5)-KU70 heterodimer (which is involved in the repair of DNA double-strand breaks), ATP-dependent RNA helicase A (RHA) and heterochromatin protein 1 (HP1) 106 . The D. melanogaster homologue of vigilin, Ddp1, localizes to heterochromatin and is essential for gene silencing in flies. Vigilin also interacts with SUV39H1, which methylates histone H3 on Lys9 (H3K9me). The H3K9me epigenetic mark provides a binding site for HP1, which mediates the formation of heterochromatin and gene silencing ↓ pre-let-7g ↓ pre-miR-151
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pri-miR-376a edited at the +4 site by ADAR2 One of those genes, specifically targeted by the edited miR-376a-5p, is PRPS1, which encodes an essential enzyme involved in purine metabolism and the uric acid synthesis pathway. Repression of PRPS1 by the edited miR-376a-5p results in reduced expression of uric acid in certain tissues, such as brain, in which uric acid levels need to be tightly regulated. The 3′untranslatedregion(UTR)ofPRPS1mRNAhastwotargetsitesforthe editedmiR-376a-5p(inset).AGO2,Argonaute2;EBV,Epstein-Barrvirus;KSHV,Kaposisarcoma-associatedherpesvirus.
RNA-induced silencing complex
(RISC). A complex containing short interfering RNAs (siRNAs) or microRNAs (mi RNAs) and an Argonaute protein, which mediates the degradation or translation inhibition of target mRNAs that have high sequence complementarity to the small RNAs.
By contrast, antagonistic effects of dAdar (which is the only known D. melanogaster ADAR gene) on hetero chromatic gene silencing of Hoppel transposable elements were reported. It was proposed that dAdar edits a long dsRNA generated from Hoppel loci, thereby preventing Dicer from processing it into endo-siRNAs, which are required for RNAi-mediated hetero chromatin formation and gene silencing 109 . However, the involvement of Dicer in this transposon-silencing mechanism and the generation of endo-siRNAs from Hoppel elements remain to be shown.
Editing of mi RNAs and its consequences
Primary miRNA (pri-miRNA) transcripts fold to form dsRNA (hairpin) structures, which are processed in the nucleus into precursor-mi RNAs (pre-mi RNAs) of ~70 nt in length by the RNase III protein Drosha, in complex with the pri-miRNA recognition factor DGCR8 (FIG. 4a ). Pre-mRNAs are then exported to the cytoplasm, where they are processed further by another RNase III protein, Dicer, in complex with TAR RNA-binding protein (TRBP; also known as TARBP2) to generate doublestranded, mature mi RNAs of ~22 nt in length. Mature mi RNAs are loaded onto Argonaute (AGO) proteins and together form the core of the RNA-induced silencing complex (RISC). The miRNA guide strand (the functional strand retained by AGO) directs the RISC to the target mRNAs, causing translation repression or mRNA decay. Nucleotides 2-8 of the guide strand, known as the seed sequence, are particu larly important in directing the selection of mRNA targets 110 . miRNA-mediated gene silencing has crucial roles in many biological processes, such as tissue differentiation, cell proliferation, embryonic development and apoptosis, and its misregulation can result in human diseases 111, 112 . Certain pri-mi RNAs undergo A-to-I editing (TABLE 2) , which affects their biogenesis and function.
Approximately 20% of pri-mi RNAs are edited in the adult human brain 21 . In addition, editing of several pri-mi RNAs encoded by DNA viruses (Epstein-Barr virus (EBV) and Kaposi sarcoma-associated herpes virus HHV-8) has been reported 20, 113, 114 . It was anticipated that next-generation sequencing of small RNAs would reveal many new A-to-I editing sites in mi RNAs. However, only a small number of new sites that are edited at significant frequency (>5% editing) were identified in mature mi RNAs, indicating that the expression of edited mature mi RNAs is relatively rare 115, 116 . This may be because editing of pri-mi RNAs results mostly in inhibition of miRNA biogenesis.
Suppression of miRNA biogenesis. ADARs can suppress miRNA maturation at different processing stages by editing-dependent and editing-independent mechanisms. The recognition of pri-miRNA hairpin structures by the Drosha-DGCR8 complex can be affected by A-to-I editing, as was first demonstrated for primiR-142. Editing of pri-miR-142 at the +4 and +5 positions (counting from the 5ʹ end of the mature miRNA sequence) by ADAR1 and ADAR2 inhibits its cleavage by Drosha-DGCR8 (REF. 24) (FIG. 4a) . As expected, the expression of miR-142-5p is substantially higher in the spleen of Adar1-and of Adar2-null mice compared with wild-type mice 24 . Although editing of pri-miR-142 prevents its processing to pre-miR-142, no accumulation of edited pri-miR-142 was detected in HEK293 cells ectopically overexpressing ADAR1 and ADAR2, owing to their degradation by EndoV-Tudor-SN 99 . Degradation of edited fly pri-miR-125, presumably by EndoV-Tudor-SN, was also reported 117 . Thus, A-to-I editing-dependent degradation of pri-mi RNAs could be considered to be a control mechanism of miRNA biogenesis and activity. Inhibition of cleavage by Drosha was also reported for pri-miR-33, pri-miR-133a2 and primiR-379 (REF. 21 ). By contrast, editing increases Drosha cleavage -although very slightly -for pri-miR-197, and substantially for pri-miR-203 (REF. 21 ), as well as for D. melanogaster pri-miR-100 (REF. 117 ). Editing of primiR-455 at the +2 and +17 positions by ADAR1 and suppression of the Drosha cleavage step were also reported in human melanocytes 62 . Suppression of ADAR1 expression, and thus reduced editing of these sites, results in increased expression of miR-455-5p and suppression of its target, the tumour suppressor cytoplasmic polyadenyl ation element-binding protein 1 (CPEB1), which could be relevant to metastasis of melanomas 62 . ADAR1 edits the -1 and +3 positions of pri-miR-151 in certain tissues, such as amygdala, cerebral cortex and lung, which results in a complete block of pre-miR-151 cleavage by Dicer-TRBP and inhibition of miR-151-3p expression 22 (FIG. 4a) . Binding of the Dicer-TRBP complex to unedited and to edited pre-miR-151 are comparable, indicating that Dicer cleavage, not binding, is inhibited by editing. Partial prevention of pre-let-7g cleavage by Dicer due to editing of the +4 position by ADAR2 was also reported 21 . Loading of miRNA onto AGO2-containing RISC can also be inhibited by editing. ADAR1 edits the +20 position of pri-miR-BART6, a miRNA encoded by the EBV, which results in the inhibition of miR-BART6-5p loading onto RISC and thus of its function; this, in turn, affects the latency state of EBV 20 (FIG. 4a) . When not edited, miR-BART6-5p specifically targets the human Dicer mRNA, which is evidence that EBV has developed a unique strategy to suppress host RNAi 20 . Thus, editing of pri-miR-BART6 by ADAR1 could have evolved as a human counteractive strategy against the suppression of RNAi by EBV.
Owing to its dsRNA-binding capacity, ADAR2 seems to sequester and thus inhibit the processing of pri-miR-376a1 and pri-miR-376a2, most probably at the Drosha cleavage step 118 . Editing-independent suppression by ADAR2 of miRNA processing and its tumour-promoting role in glioblastoma were also proposed 119 . Expression of mi RNAs is indeed altered in Adar2-null mouse embryos, most probably through an editing-independent mechanism 120 . ADAR1 also suppresses the expression of many mi RNAs, including the stem cell self-renewal-promoting miR-302 family of mi RNAs, in an RNA editing-independent manner, which is essential for neural differentiation of human ES cells 121 . Editing-independent suppression of miR-222 expression by ADAR1 and the consequent upregulation of ICAM1, and the relevance of this to melanoma immune resistance, have also been reported 122 . Finally, global screening for ADAR1-binding sites suggested that ADAR1 might compete with DGCR8 for binding to many pri-mi RNAs 123 . Thus, a larger subset of mi RNAs than those edited might be affected by both ADAR1 and ADAR2, independently of their catalytic functions.
Alteration of miRNA target specificity. In some cases pri-miRNA editing does not inhibit miRNA maturation, leading to the expression of edited mature mi RNAs that can be loaded onto AGO2-RISC. However, as editingeven at a single site -can alter the base pairing properties of the miRNA, it can also affect recognition of its target mRNA, especially if editing takes place within the seed sequence of the miRNA.
Members of the miR-376 cluster are transcribed as one transcript and processed to individual pre-miRNAs 23 . In miR-376a, at least two main sites are edited, corresponding to +4 (located in the 5p seed sequence) and +44 (or alternatively numbered as the +6 site; located in the 3p seed sequence). ADAR2 edits the +4 site, whereas ADAR1 edits the +44 site. Interestingly, edited miR-376a targets an almost completely different set of genes than unedited miR-376a. One of the targets specific to the miR-376a-5p edited at the +4 site is phosphoribosyl pyrophosphate synthetase 1 (PRPS1), which is an essential enzyme involved in purine metabolism and in the uric acid synthesis pathway (FIG. 4b) . A human disorder characterized by gout and neurodevelopmental impairment with hyperuricaemia is caused by substantially increased PRPS1 expression, indicating the importance of tightly regulated expression of this enzyme. Adar2-null mice have both PRPS1 and uric acid levels upregulated approximately twofold in the cortex. No increase in PRPS1 or uric acid levels was detected in the livers of Adar2-null mice, consistent with the fact that the +4 site is barely edited in wildtype mouse liver 23 . This proves that editing of the +4 site of pri-miR-376a by ADAR2 tightly regulates uric acid levels in a tissue-specific manner by redirecting miRNA target specificity 23 (FIG. 4b) . Editing of miR-376 cluster mi RNAs increases from embryonic day 19 (E19) in mouse embryos, suggesting that it may be important for embryo development 124 . Furthermore, the differential silencing of RAS-related protein RAP2A and of the E3 ubiquitin ligase AMFR by unedited and edited miR-376a-5p, respectively, were reported to affect glioblastoma metastasis 125 . Seed sequence editing of several other mature mi RNAs has also been reported 21, 114, 124 and is likely to alter target gene specificity (FIG. 4a) . Silencing of the tumour suppressor Dice1 (deleted in cancer 1; also known as Ints6) by the EBV-encoded miR-BART3-5p is antagonized owing to editing of pri-miR-BART3 at the +5 site (seed sequence) by ADAR1 (REF. 113 ).
Regulation of RNAi by ADARs
Both A-to-I RNA-editing and RNAi pathways act on dsRNA. It has been speculated that the A-to-I editing and RNAi may interact with each other by competing for shared dsRNA substrates 126 . Indeed, the two processes antagonistically interact (FIG. 5a ) (see the discussion on miRNA editing in the previous section and the discussion below). Conversely, a stimulative interaction between RNA editing and RNAi machinery proteins exists, as ADAR1 forms a complex with Dicer and promotes its activity (FIG. 5b) .
Suppression of RNAi. Analyses of ADAR-null C. elegans
strains have revealed the presence of an antagonistic interaction between A-to-I RNA-editing and RNAi pathways 127, 128 . C. elegans strains that contain homozygous deletions of both adr1 and adr2 genes have a chemotaxis-defective phenotype 128 , which is rescued by crossing these worms with RNAi-defective worms, indicating that enhanced RNAi leading to the suppression of a chemotaxis gene underlies the chemotaxis-defective phenotype of ADAR-null worms 127, 128 . A-to-I RNA editing of a dsRNA made of a chemotaxis gene transcript could perhaps inhibit its silencing by RNAi 127, 128 (FIG. 5a) .
However, details of the putative interaction between RNA editing and RNAi, as well as the identity of the chemotaxis gene, remain unknown.
It has recently been reported that endo-siRNAs derived from loci enriched with inverted repeats and transposons are dramatically upregulated in ADARnull mutant worms. A-to-I RNA editing of dsRNA regions of transcripts derived from these loci seems to inhibit their entry into the RNAi silencing pathway and to consequently suppress synthesis of endosiRNAs from these transcripts 129 . A separate study suggested that biogenesis of not only endo-siRNAs, but also of mi RNAs, is significantly affected in ADARnull mutant worms 130 (FIG. 4a) . In the fruit fly white+ eye reporter system, antagonistic effects on RNAi were observed by the introduction of human ADAR1p150, but not of ADAR1p110 or ADAR2. Interestingly, it is not the A-to-I editing but the dsRNA-binding activity of ADAR1p150 that seems to be responsible for its RNAi-antagonistic function 118 .
ADAR1 interacts with Dicer and promotes its activity.
Analysis of proteins that interact with epitope-tagged Dicer or ADAR1 has revealed a robust and direct interaction between Dicer and ADAR1 (REF. 26 ). Although both ADAR1p150 and ADAR1p110 can form the complex in vitro, ADAR1p110 seems to be the true partner of Dicer in vivo 25 . ADAR1 distinguishes between its functions in RNA editing and in RNAi by the formation of two different complexes: ADAR1-ADAR1 homodimers in the nucleus for RNA editing, and Dicer-ADAR1 hetero dimers in the cytoplasm. ADAR1 in complex with Dicer has no A-to-I RNA-editing activity, perhaps reflecting the fact that homodimerization is required for its A-to-I RNA-editing activity 63 . In addition to Dicer, ADAR1 interacts indirectly with AGO2 through its interaction with Dicer, resulting in the formation of Dicer-ADAR1-AGO2 complexes of ~450 kDa in size 26 . Dicer contains a DEAD-box RNA helicase domain in its N-terminal region, followed by DUF283 and PAZ domains, two catalytic RNase III domains, and a dsRNA-binding domain at the C-terminus. The second dsRBD (dsRBD2) of ADAR1, and the DEAD-box RNA helicase and DUF283 domains of Dicer, are required for the formation of the Dicer-ADAR1 complex 26 . In principle, ADAR1 as part of the Dicer-ADAR1 complex could be inhibitory with respect to Dicer function. In fact, however, it increases the V max of Dicer-mediated cleavage of pre-mi RNAs fourfold in comparison with the reaction with Dicer alone 26 . Similar analyses on Dicer cleavage of a long dsRNA indicated that ADAR1 also promotes processing of endo-siRNAs, showing that ADAR1 upregulates the turnover rate of Dicer and substantially increases the overall rate of miRNA and endo-siRNA production 26 (FIG. 5b) . mi RNAs generated by the Dicer-ADAR1 complex were found to be fully functional when tested in various miRNA silencing assays 26 . In addition, ADAR1 substantially promotes RISC assembly and loading of mi RNAs 26 (FIG. 5b) .
Interestingly, neither the dsRNA-binding nor the deamin ase activities of ADAR1 is required for promoting the miRNA-processing and RISC-loading activities of Dicer. The catalytic activity of Dicer is auto-inhibited by its DEAD-box RNA helicase domain 131 . Thus, the enhancement of Dicer activity by ADAR1 may be due to ADAR1 binding to the Dicer DEAD-box RNA helicase domain, thereby blocking its auto-inhibitory effect 26 . ADAR1 upregulates miRNA expression in mouse embryos. Analysis of miRNA expression levels in mouse embryos indicates that a rapid and dramatic increase of miRNA production occurs globally at around E11-E12 (REFS 25, 26) , which is likely to be essential for embryo development. This developmental stage-specific increase in miRNA production seems to be caused by concomitant upregulation of Dicer and ADAR1p110 (REF. 26 ). Global suppression of miRNA production is detected in Adar1-null mouse embryos, which die at around E12 (REFS 25, 26) . In contrast to the rapid increase in ADAR1p110 expression, TRBP expression remains very low around this period, perhaps indicating that the contribution of ADAR1 is more important than that of TRBP in the miRNA-mediated RNAi mechanism, at least during embryonic development of the E11-E12 stage 26 . The considerable upregulation of miRNA production at the E11-E12 stage cannot occur in Adar1-null mouse embryos, owing to the lack of the Dicer-ADAR1p110 complex 25, 26 . This seems to result in dysregulated expression of many genes, which would otherwise be repressed by these mi RNAs during normal development, as drama tic changes of global gene expression patterns are detected in the Adar1-null embryos. The target genes have different functions, but cell death control and activation of interferon signalling are two of the most signifi cant functions represented 26 . Thus, deficiency in the RNAi function of ADAR1 may underlie, at least partly, the embryonic lethality of Adar1-null mice around E12 (REFS 25, 26) .
Concluding remarks and outlook
It is now almost 30 years since the discovery of A-to-I RNA editing mediated by ADAR 4, 5 . Since then, considerable progress has been made in understanding the editing mechanism, characterizing invertebrate and vertebrate ADAR genes, identifying numerous A-to-I editing sites in a wide range of coding and non-coding RNAs, and unravelling the relevance of A-to-I RNA editing to human diseases and revealing its interactions with RNAi pathways.
Nonetheless, we realize that many important questions in this field remain to be answered. For example, what is the selective advantage that initially drove the evolution of A-to-I RNA editing in the animal kingdom? ADAR genes are absent in plant, fungi and yeast genomes. In these organisms, very powerful RNAi pathways utilize dsRNA and play a major part in many important processes, such as silencing of transposons and heterochromatin formation. Did A-to-I RNA editing evolve as a mechanism to assist or replace RNAi? ADAR expression levels are not necessarily correlated well with A-to-I RNA-editing levels of target RNAs within a given tissue or developmental stage, indicating the presence of a currently unidentified mechanism (or mechanisms) that determines editing levels. Certain ADAR gene family members seem to have functions in addition to A-to-I RNA editing, for example, the function of ADAR1 in RNAi. However, it is not known how the balance between the A-to-I RNA-editing and the RNAi functions of ADAR1 is regulated. Exciting findings are likely to be made in the field of A-to-I RNA editing, through future investigations addressing these questions.
